Article Text
PDF
Abstract
We assessed referring medical practitioner’s ability to predict chronic fatigue development in adolescents presenting with acute infectious mononucleosis. Compared with ‘not fatigued’ being predicted as ‘unsurely fatigued’ and ‘likely fatigued’ were both strongly associated with developing fatigue 6 months later (OR 2.5, 95% CI 1.16% to 5.47% and 3.2, 95% CI 1.19% to 8.61%, respectively, P=0.012). The positive and negative predictive values were 66% and 62%, respectively. Disentangling the physician’s intuition may be of interest in further investigations of risk factors and prophylactic factors for fatigue development.
- adolescent health
- chronic fatigue syndrome
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Introduction
Infectious mononucleosis (IM), normally caused by Epstein-Barr virus (EBV), is a common infection in adolescence and a well-known trigger of chronic fatigue (CF) and chronic fatigue syndrome (CFS); 11–13,5% of IM-patients are diagnosed with CFS 6 months after acute EBV-infection.1–3 The present study is part of the CEBA-project (CF following acute EBV-infection in adolescents, post-results), and in this research letter we aimed at assessing the referring medical practitioners’ ability to predict fatigue development based on their initial encounter with EBV-infected adolescents.
Method
The CEBA-project (ClinicalTrial ID: NCT02335437) has been approved by the Norwegian Committee for Ethics in Medical research. Participation was based on written informed consent.
Patient and Public Involvement (PPI)
Patients were not directly involved in the design of the CEBA-project.
Individuals with a serological pattern indicating acute EBV-infection, age between 12 and 20 years and living in South-East Norway were eligible for participation in CEBA; exclusion criteria were more than 6 weeks since debut of symptoms, medication due to chronic disease and pregnancy. Patients enrolled in the study were extensively investigated during the acute infection episode (baseline) and 6 months later; details of the investigational programme are provided elsewhere.3 Fatigue (predefined primary endpoint) was assessed by the Chalder Fatigue Questionnaire (CFQ); bimodal scoring (0-0-1-1) was applied, and in line with earlier studies, a total score of four or higher was considered a case of CF.4
At baseline, a short questionnaire was administered to the physicians who requisitioned the primary EBV analyses (online supplementary file), asking them to guess whether the particular teenager would develop CF 6 months later or not; possible answers were ‘Yes’, ‘No’ and ‘Don’t know’. The questionnaire also charted initial symptoms and signs during the consultation, as well as simple demographic information.
Supplemental material
SPSS statistical software (IBM SPSS Statistic 24 Inc., Chicago, IL, USA) was used for statistical analyses. Primarily we performed binary logistic regression analysis with CF at 6 months as dependent variable (CFQ total score ≥4 or <4) and the prediction (Yes/No/Don’t know) given by the referring physician at baseline as independent variable. Secondarily, sex, C reactive protein (CRP) measured by the referring units and the physician’s work experience (time in years) were included in the model. A p value of <0.05 was considered statistically significant.
Results
A total of 200 patients with acute EBV infection were included in the CEBA-project; five were lost to follow-up 6 months later. A total of 165 physicians returned the questionnaire, yielding a complete dataset for 161 patients that were subjected to further analyses. A comparison of patients from physicians that returned and did not return the questionnaire showed no significant difference (table 1).
Comparison of patients with referring medical practitioner not responding versus referring medical practitioner responding to questionnaire administered per mail
Compared with ‘not fatigued’, being predicted as ‘unsurely fatigued’ and ‘likely fatigued’ were both strongly associated with being fatigued 6 months later (OR 2.5, 95% CI 1.16% to 5.47% and 3.2, 95% CI 1.19% to 8.61%, respectively, P=0.012). Neither gender, CRP nor the doctors work experience had significant impact on the OR estimate when included in the model. The positive and negative predictive values were 66% and 62%, respectively. Of the observed patients, 75% of the non-fatigued were predicted correctly, while only 18% of the fatigued got a correct prediction (table 2).
Predicted and observed fatigue 6 months after acute Epstein-Barr virus-infection
Discussion
Low sensitivity and specificity reject the physicians’ intuition as a suitable screening tool for fatigue development following an acute EBV-infection, still the present report shows that the physician’s prediction of fatigue development significantly relates to actual fatigue status 6 months later. Disentangling the physician’s intuition may be of interest in further investigations of risk factors and prophylactic factors for fatigue development.
Footnotes
Contributors TTA, MP and VBW conceptualised and designed the study, carried out the statistical analyses, drafted the initial manuscript and reviewed and revised the manuscript. ES supervised statistical analyses and critically reviewed and revised the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.